Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


27 September, 2022

Updates and announcements

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine


From October 5th to October 7th, Hyris will be present at the SIBioC 2022 in Genova, to present Hyris marketplace approach and Hyris SystemTM disruptive featuresfor laboratory medicine.

Our team will discuss with partners and prospects at Hyris stand First Floor, bar area.